| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 51 |
| 1 | RITUXIMAB | 48 |
| 2 | DEXAMETHASONE | 43 |
| 3 | DEXAMETHASONE 1.5 MG | 43 |
| 4 | TACROLIMUS | 42 |
| 5 | MYCOPHENOLATE MOFETIL | 39 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 39 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 38 |
| 8 | TACROLIMUS OINTMENT 0.1% | 38 |
| 9 | PREDNISOLONE | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETOPOSIDE PHOSPHATE | 5 | 0.0031 |
| 1 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 7 | 0.0009 |
| 2 | POLATUZUMAB VEDOTIN | 8 | 0.0008 |
| 3 | AMPICILLIN INJECTION | 5 | 0.0007 |
| 4 | BENDAMUSTINE HCL | 10 | 0.0006 |
| 5 | AMPHOTERICIN B | 8 | 0.0006 |
| 6 | MAGNESIUM SULFATE HEPTAHYDRATE | 8 | 0.0006 |
| 7 | AMPICILLIN | 5 | 0.0006 |
| 8 | BENDAMUSTINE HYDROCHLORIDE | 5 | 0.0006 |
| 9 | CEFEPIME HYDROCHLORIDE | 9 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 135 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 50 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 36 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 4 | Alkylating Drug [EPC] | 28 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 23 |
| 6 | Azole Antifungal [EPC] | 21 |
| 7 | Proton Pump Inhibitor [EPC] | 20 |
| 8 | Benzodiazepine [EPC] | 19 |
| 9 | Loop Diuretic [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 1 | Lipid-based Polyene Antifungal [EPC] | 8 | 0.0006 |
| 2 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 3 | Anti-coagulant [EPC] | 2 | 0.0005 |
| 4 | Contrast Agent for Ultrasound Imaging [EPC] | 3 | 0.0005 |
| 5 | Antimalarial [EPC] | 4 | 0.0004 |
| 6 | Antiprotozoal [EPC] | 4 | 0.0004 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 8 | Anthelmintic [EPC] | 1 | 0.0003 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |